139 related articles for article (PubMed ID: 34176301)
1. Safety of intravitreal triamcinolone and its impact on optic nerve morphology in patients treated for diabetic macular edema.
Carreira AR; Marques N; Carreira P; Moraes F; Loureiro T; Telles Freitas P; Cardoso J; Campos N
Eur J Ophthalmol; 2022 May; 32(3):1596-1601. PubMed ID: 34176301
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
3. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.
Cellini M; Pazzaglia A; Zamparini E; Leonetti P; Campos EC
BMC Ophthalmol; 2008 Mar; 8():5. PubMed ID: 18366650
[TBL] [Abstract][Full Text] [Related]
5. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
Storey PP; Obeid A; Pancholy M; Goodman J; Borkar D; Su D; Regillo C
Retina; 2020 Jan; 40(1):75-79. PubMed ID: 30308561
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M
Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
[TBL] [Abstract][Full Text] [Related]
9. [Diffuse diabetic macular edema. Intraocular pressure after intravitreal triamcinolone acetonide].
Kreissig I; Degenring RF; Jonas JB
Ophthalmologe; 2005 Feb; 102(2):153-7. PubMed ID: 15316734
[TBL] [Abstract][Full Text] [Related]
10. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
Kuley B; Storey PP; Wibbelsman TD; Pancholy M; Zhang QE; Sharpe J; Bello N; Obeid A; Regillo C; Kaiser RS; Chiang A; Fineman MS; Vander JF; Gupta OP; Spirn MJ; Dunn JP; Mehta S; Park CH; Maguire JI; Garg S
Curr Eye Res; 2021 Jun; 46(6):824-830. PubMed ID: 33522311
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
Lim JW; Lee HK; Shin MC
Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
[TBL] [Abstract][Full Text] [Related]
14. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
16. Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Wei Y; Wang HZ; Chen FH; Wang RS; Yang XG
Eye Sci; 2012 Dec; 27(4):182-7. PubMed ID: 23225839
[TBL] [Abstract][Full Text] [Related]
17. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
Wykrota AA; Abdin AD; Munteanu C; Löw U; Seitz B
Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3569-3579. PubMed ID: 37432451
[TBL] [Abstract][Full Text] [Related]
18. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema.
Parolini B; Panozzo G; Gusson E; Pinackatt S; Bertoldo G; Rottini S; Pignatto S
Semin Ophthalmol; 2004; 19(1-2):1-12. PubMed ID: 15658006
[TBL] [Abstract][Full Text] [Related]
19. The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment.
Hong IH; Choi W; Han JR
Jpn J Ophthalmol; 2020 Mar; 64(2):196-202. PubMed ID: 31900869
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Audren F; Lecleire-Collet A; Erginay A; Haouchine B; Benosman R; Bergmann JF; Gaudric A; Massin P
Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
